Roche RHHBY announced that it will advance pipeline candidate prasinezumab into phase III development for early-stage Parkinson’s disease. Roche has a licensing agreement with Prothena PRTA for ...
According to the paper, artificial intelligence addresses a core weakness in Parkinson’s care: reliance on subjective ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Job cuts include the company's U ...
Verywell Health on MSN
Akinesia associated with Parkinson's disease and other causes
Medically reviewed by Nicholas R. Metrus, MD Key Takeaways Akinesia is a condition where you cannot make voluntary movements, ...
Scientists report that specific RNA patterns in blood may detect Parkinson’s disease early, opening a window for earlier care ...
Some Parkinson’s patients may experience strange symptoms, like smell loss and sleep disorders, decades before diagnosis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results